Proactive Licensing Initiatives
In addition to expanding the ONO Group pipeline through our in-house research, we are also actively pursuing licensing activities with the aim of drug discovery collaboration for the development of innovative products and in-licensing new drug candidates that are under development by pharmaceutical or bioventure companies around the world including Japan.Our in-licensing efforts focus on compounds deemed to be strategic and efficient from a business perspective, and compounds deemed to be viable from the perspective of diseases with high medical needs.
Drug discovery partnerships & Research collaborations
At ONO PHARMA USA, we promote drug discovery and research collaborations, primarily in North America, with biotech companies, startups, and academic institutions. By working together with partners who possess cutting-edge research technologies and expertise, we aim to create innovative medicines and strengthen the ONO Group’s research and development capabilities. Through these activities, we contribute to the development of new therapies that address unmet medical needs for patients.
Licensing and Co-promotion
At ONO PHARMA USA, we are actively pursuing the commercialization of existing products, as well as the in-licensing of development-stage and new drug candidates. Through collaborations with pharmaceutical and biotech companies, primarily in the U.S.and Europe, we aim to expand the ONO Group pipeline and create innovative therapies. We also focus on exploring business opportunities in therapeutic areas with high unmet medical needs, taking into account our business strategy and market demands. Through these activities, we strive to deliver new value to patients.
For Partnership and Business Development Inquiries
If you are interested in licensing, co-promotion, or research collaboration opportunities with ONO PHARMA USA, please contact our team.